Core Insights - Onconetix, Inc. has appointed David White as Chief Executive Officer and Sammy Dorf to its Board of Directors, reflecting a strategic move to enhance leadership as the company prepares for the acquisition of Realbotix LLC, a developer of AI-powered humanoid robots [1][2][3] Leadership Appointments - David White brings over 30 years of executive experience, having held CEO, CFO, and COO roles in various sectors including transportation and healthcare. He has served on multiple public company boards and holds a CPA designation [2][4] - Sammy Dorf is an entrepreneur and investor with a strong background in capital markets and corporate governance. He co-founded Verano Holdings Corp. and has held significant roles in public companies, contributing to their strategic transformations [3][4] Acquisition of Realbotix - The acquisition of Realbotix is seen as a transformative opportunity for Onconetix, positioning the company at the intersection of AI and humanoid robotics, which is a rapidly evolving sector [3][5] - The leadership team believes that the acquisition will create significant value for shareholders and is focused on executing the transaction successfully [5][6] Company Background - Onconetix, Inc. is a commercial-stage biotechnology company specializing in innovative oncology solutions, including Proclarix®, an in vitro diagnostic test for prostate cancer [6] - Realbotix LLC, the target of the acquisition, develops AI-powered humanoid robots designed for human interaction, with patented technologies enabling lifelike expressions and social engagement [7]

Core Viewpoint - Realbotix Corp. has appointed Scott Meyers as the new Chief Financial Officer, effective January 12, 2026, marking a significant leadership transition as the company continues its global expansion in AI and humanoid robotics [1][2][4]. Group 1: Leadership Transition - Scott Meyers brings over 22 years of experience in corporate finance and public-company reporting, with a focus on scaling technology-focused organizations [2]. - Martin Bui, the current CFO, will transition out of his role in early 2026 but will remain with the company to ensure a smooth handover during year-end financial reporting [3]. - CEO Andrew Kiguel expressed gratitude for Martin Bui's contributions during a critical growth phase and highlighted the excitement surrounding Scott Meyers' appointment to drive the next stage of growth [4]. Group 2: Company Overview - Realbotix designs and manufactures AI-powered humanoid robots aimed at entertainment, customer service, and companionship, positioning itself as a leader in human-centric robotics [5]. - The company's patented technologies enable lifelike expressions, motion, vision, and social engagement, contributing to its competitive edge in the rapidly evolving robotics field [5].